Kringle

4884.T

Tags: JP Healthcare Biotechnology

Kringle Pharma, Inc. Price (4884.T)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

6,399,270

(18.7203)%

Market Cap of Kringle (4884.T)

Market cap:

As of , 4884.T has a market cap of . This makes 4884.T the 2574th most valuable company in the JP by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $471-1328
Market Cap 5.78B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Kiichi Adachi Ph.D.
IPO Date: December, 28, 2020
Country: JP
Currency: JPY
Headquaters: No Data
Employees: 15

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: